Objectives: To test whether overweight or obese employees who achieve clinically significant weight loss of Z5% have reduced medical expenditures, absenteeism, presenteeism, and/or improved Health-Related Quality Of Life (HRQOL).
O besity rates in the United States have reached epidemic proportions, even among full-time employees. Currently, over 28.5% of full-time employees are obese [ie, have a body mass index (BMI) of >30] and another 38% are overweight (ie, have a BMI between 25 and 30). 1 There are many health and economic costs associated with overweight and obesity in the workplace. This includes reduced Health-Related Quality Of Life (HRQOL) among employees and higher incidence of chronic diseases, [2] [3] [4] which translates into higher medical expenses, 5 health insurance rates, 6, 7 rates of absenteeism and presenteeism, [8] [9] [10] and ultimately, reduced firm profitability.
This suggests that health and, depending on the cost of the intervention, firm profitability could be improved by successful efforts to reduce the prevalence of overweight and obesity in the workplace. Whereas some of these efforts have been successful at achieving weight loss or other health gains among employees, 11, 12 there is limited evidence that these programs are cost saving. 13 This may result because the few studies that addressed cost implications were based on studies with only modest weight loss. 13 To address this concern, Finkelstein et al 14 compared changes in medical expenditures and absenteeism among overweight full-time employees at North Carolina Community Colleges who took part into a weight loss study (referred to as CDC-WAY throughout) stratified by degree of weight loss. The hypothesis tested was that those who lost Z5% weight-a weight loss level that has been shown to yield clinical health benefits 15 -regardless of which arm of the study they were in, would have lower medical expenses and less absenteeism upon study conclusion (and after 18 mo for medical expenditures) than those who gained weight or lost <5% of baseline weight. The authors were unable to reject the null hypothesis of no difference in outcomes (medical expenses and absenteeism) between the 2 groups at follow-up. However, the samples analyzed were small (667 individuals for absenteeism and 279 for medical expenditures) and <20% of the participants showed Z5% weight loss. Consequently, the study findings were associated with large confidence intervals, which reduced the chances of finding statistically significant differences between groups.
To address this concern, this analysis revisits and extends the original study by using, in addition to data from CDC-WAY, identical data from a similar weight loss study, NHLBI-WAY, targeting faculty and staff in other North Carolina colleges and universities. In addition, NHLBI-WAY data also allow us to test whether those with >5% weight loss showed greater improvements in HRQOL, which is a likely mediator of improvements in medical expenditure and absenteeism, and to extend the analysis by measuring the impact that weight loss has on presenteeism. The latter allows for a more comprehensive assessment of the effect that weight loss has on employee productivity. This analysis also employs nonlinear statistical models in an effort to improve the efficiency of the estimates. Altogether, the larger sample size, improved methodology, and expansion to include HRQOL and presenteeism will provide a more rigorous test of whether or not programs that are successful at inducing clinically significant weight losses among employees can also yield short-term financial benefits to the employers who offer them. If we find short-term benefits, financing the cost of these programs could provide justification for employers to increase the availability of weight loss programs for employees.
METHODS

Study Design
The first source of data, CDC-WAY, was a study conducted among overweight and obese employees at 17 community colleges in North Carolina. The study was designed to test the effectiveness of three 12-month long weight loss interventions: a low-cost environmental change intervention, a web-based weight loss program, and a webbased weight loss program plus financial incentives. Details of the recruitment strategy of the 935 participants and their demographics are described elsewhere. 16 The second study, NHLBI-WAY, was designed to rigorously test the independent and combined effects of a self-directed web-based weight loss intervention. Participants in the incentive arm were eligible for up to $150 in CDC-WAY and up to $160 at the 12-month weigh-in in NHLBI-WAY, where payments were based on percentage of baseline weight lost. NHLBI-WAY was conducted over 18 months among employees from 12 different North Carolina universities, historically black colleges, and community colleges. Recruitment methods of 933 participants and eligibility criteria were nearly identical to that used in the previous study. Therefore, the 2 samples are expected to be highly comparable. In each study, those who consented to participate were asked to sign a second consent allowing access to their health insurance claims data from the North Carolina State Health Plan for Teachers and Employees. Survey data and measured height and weight were collected between August 2005 and November 2006 for CDC-WAY and from September 2008 through June 2010 for NHLBI-WAY. The participants of both studies had height and weight measured by a trained research team member and completed questionnaires at baseline and at several measurement points, including a 12-month assessment which, for consistency, is the primary endpoint used in this analysis. The questionnaires captured basic demographic data, diet, and exercise patterns, and notably the EQ-5D-3L 17 measure of HRQOL (NHLBI Only), a 1-item question on absenteeism, and the Stanford Presenteeism Scale SPS-6. 18 Claim data were extended to include additional 1.5 years after 12-month weigh-in for both studies. To address privacy concerns during Institutional Review Board (IRB) review, individuals with any evidence of claims related to mental health, substance abuse, human immunodeficiency virus infection/acquired immunodeficiency syndrome, other communicable diseases, or genetic testing were not included in the final claims dataset. All other claims for covered services for all consenting participants were made available to the research team. Both studies were approved by the IRBs at the University of North Carolina at Chapel Hill, the Research Triangle Institute (CDC-WAY only), and at each participating institution.
Dependent Variables
The EQ-5D-3L algorithm converts each participant's responses to the 5 EQ-5D 3-level questions into a HRQOL score that ranges between 0 (death) and 1 (perfect health). Note that EQ-5D-3L scores were available for NHLBI-WAY participants only and that negative scores (for health states deemed worse than death) are not observed in our sample of working employees. Absenteeism was measured in both studies as the self-reported number of days missed from work because of illness or injury over the 30 days preceding the measurement points. The SPS-6 scores range from 6 for those who do not suffer from presenteeism, in the sense that they can concentrate on and perform their work despite being overweight, to 30 for those whose work is most adversely affected by their weight. For tractability, we created a 4category scale of presenteeism by aggregating the SPS-6 scores as follow: 6 for no presenteeism (55% of the sample), 7-9 for low presenteeism (19%), 10-15 for moderate presenteeism (16%), and 16-30 for high presenteeism (11%). Quarterly amounts of medical expenditures paid by the health insurer (net of claim reversals) were computed during the intervention, 12 months before, and 18 months beyond the 12-month measurement point for both the studies. In the primary analysis of this study, inpatient expenses were not included in the totals because of their limited number and large variance. All expenditures were converted to quarter one 2010 prices by means of the medical component of the consumer price index. 19 
Statistical Analysis
Following Finkelstein and colleagues, the analyses rely on a difference-in-difference 20 identification strategy where changes in the dependent variables from baseline to followup (the first difference) are compared between those who did or did not show evidence of Z5% weight loss (the second difference). Individuals with missing weight loss at followup but whose medical claims or survey data were available were included in the analyses and assumed to have <5% weight loss using an intention-to-treat analytic strategy. Because the primary research question is independent of study arm, this allowed for pooling individuals from different study arms across the 2 studies. We merely need to know whether each participant was successful at achieving Z5% weight loss; how the weight loss was achieved is immaterial for assessing its impact on these outcomes.
To estimate the effect of Z5% weight loss, in each model we regress the dependent variable on a binary variable indicating Z5% weight loss (vs. not), a binary variable indicating the follow-up (vs. baseline) period, and an interaction between these 2 variables. We also include the following control variables: age, baseline BMI, and binary variables indicating sex, ethnicity, faculty members, the study, intervention arms, and one dummy indicating whether the participant has any of the following comorbidities: diabetes, chronic dizziness, bone or joint problems, chest pains, or a past stroke/heart attack (or not). For the medical expenditures analysis, an additional binary variable is used to identify the quarters in the 1.5 year after 12-month weigh-in and an interaction variable between this variable and the binary variable indicating 5% weight loss.
To both improve efficiency and avoid biases, 21 we use nonlinear models for the above regressions. Note that with such models, the interaction term no longer represents the difference-in-difference estimate of the treatment effect, 22 but this effect can be estimated by computing differences in changes in predicted outcomes for each treatment group from baseline to follow-up and using the bootstrap method to test for significance in the difference of the changes. In what follows, we describe the nonlinear models used to explain HRQOL, absenteeism, presenteeism, and medical expenditures.
The EQ-5D-3L measure of HRQOL, which takes values between 0 and 1 in our sample, is characterized by a large number of individuals (48% of the sample) reporting a score of 1, perfect health. To account for this and to ensure the predictions fall into the 0-1 range, we apply the 2-part model used by Oberhofer and Pfaffermayr 23 in a similar context. The first part of the model consists of a logit model that predicts whether the individual reports perfect health. The second part is a fractional response model 24 only estimated for those with less than perfect health. The estimates are then combined as follows to estimate predicted scores for each person:
where the probability of perfect health is estimated with the logit model and the conditional expectation for those with less than perfect health is estimated with a fractional logit model; X is a vector of control variables.
The absenteeism variable is characterized by a large number of 0 outcomes (79% of the sample), which we deal with by applying a hurdle model that can be viewed as a 2part model in the context of count data. 25 The first part is a logit model explaining whether the individual has missed any work and the second part is a truncated negative binomial model explaining the number of days missed for those who missed at least 1 day. The 2 parts are combined in a similar way as above to compute expected days missed for each individual in the sample. As for the presenteeism model, after verifying that the assumption of proportional odds holds, 26 we have estimated it using a single-ordered logit regression.
Quarterly total health care claims data are characterized by a large number of individuals with 0 dollar claims (on average 23.5% of the sample each quarter) and, for those who do have claims, the distribution of expenditures is highly right-skewed with a small number of very expensive claims. To account for this, we again employ a 2-part regression model. The first part is a logit model explaining the probability of participants having a positive claim. The second part estimates medical expenditures conditional on having positive expenditures using a generalized linear model with logarithmic link and a gamma distribution to account for the skewness of the expenditure distribution. 27 Note that the link and distribution have been chosen using the Box and Cox 28 and Park and colleagues' 29, 30 tests. Results are then combined to compute expected expenditures for each individual in each period. To increase the efficiency of all estimations, we fit Generalized Estimating Equation population-averaged panel data model that account for correlations at individual level. 31 All estimations were performed using Stata 11 and inference performed by means of a nonparametric bootstrap with 1000 repetitions. Table 1 presents the combined study samples for the analysis of HRQOL, absenteeism, presenteeism, and health expenditures. The CDC-WAY study enrolled 935 eligible participants and NHLBI-WAY enrolled 933, amounting to a combined baseline sample of 1868 participants. HRQOL and presenteeism come from NHLBI-WAY only. After 12 months, 631 (67% of baseline) participants provided information on HRQOL. There were no statistically significant differences in baseline characteristics between respondents and nonrespondents. Among all HRQOL respondents, 105 (17%) lost over 5% of their baseline weight over the 12month follow-up period. A total of 1137 participants (61% of enrollees at baseline) provided absenteeism data after 12 months. As for comparison of baseline characteristics between respondents and nonrespondents (not reported in the table) we find that respondents were slightly younger on average (46.3 vs. 47.2, P = 0.04) and a higher proportion was female (84.2% vs. 81.4%, P = 0.03). Of this sample, 197 (17%) lost Z5% of baseline weight. Finally, 1409 participants (75% of enrollees at baseline) consented to allow access to their medical claims; of these, 365 (25%) were not provided because of the presence of at least one of the exclusionary diagnosis codes (listed in the table). A further 106 (11%) were not enrolled in the State Health Plan. This left an analysis sample of 938 for the medical claims analysis of which, 114 (12%) lost Z5% weight. Respondents were slightly older (47.3 vs. 45.4, P = 0.001) and more were male (19.7% vs. 13.1%).
RESULTS
Analysis Samples
The top portion of Table 2 compares baseline demographics between those who did or did not lose Z5% weight for each analysis sample. There were no statistically significant differences in baseline characteristics for any of the 4 samples analyzed. The only exception is that the percentage of faculty members was slightly higher and age slightly lower among those who have successfully lost Z5% weight in the absenteeism sample. The bottom portion of Table 2 compares differences in weight change and the outcome variables of interest. Those who lost Z5% weight averaged about 9% weight loss in each sample, or nearly 19 pounds. Those whose weight loss did not exceed this threshold gained about 1 pound on average over the 1-year period of study, revealing a roughly 20-pound difference in weight at 12 months. At baseline, those who went on to lose Z5% weight had slightly better outcomes in all models. These differences are controlled for in the difference-in-difference analysis. Table 3 presents predictions at baseline and follow-up and the difference-in-difference estimates for those who did or did not lose Z5% weight for each variable of interest with corresponding regressions results available in Appendix Table 1 , http://links.lww.com/MLR/A448. Concerning HRQOL, those who lost Z5% weight showed almost no change in EQ-5D-3L scores, whereas those who did not saw their score deteriorate. As a result, the difference-in-difference estimate is positive and statistically significant, with a positive difference in HRQOL score of 0.026 (P-value = 0.03) for those who lost Z5% weight compared with those who did not. Absenteeism rates increased for both the groups at follow-up. However, the difference-in-difference estimate provides marginal statistical evidence at the 10% level (P-value = 0.093) that weight loss resulted in a reduction in absenteeism of 0.26 d/mo relative to those who did not lose Z5% of baseline weight.
The table then outlines results from the presenteeism analyses. Results show a 6.3% greater probability of not having any presenteeism for those with Z5% weight loss and lower probabilities for greater levels of presenteeism. However, the only result that is marginally statistically significant (P-value = 0.083) is the reduction by 3 percentage points in the probability of showing low presenteeism.
The last 3 lines show predicted quarterly health expenditures for the preintervention, intervention, and postintervention periods. Comparing row 1 with row 2, we see that those who lost Z5% weight had significantly lower medical expenditures during the preintervention period. This suggests that those who went on to lose Z5% weight had a different medical profile than those who did not. Regardless, after controlling for these differences, the difference-in-difference estimates for the intervention and postintervention periods are not statistically significant, suggesting that weight loss did not positively influence medical expenditures over this period relative to those who did not lose the weight.
DISCUSSION
This study builds off of a prior analysis that showed no statistically significant improvements in absenteeism or medical expenses as a result of clinically relevant weight loss. 14 This study also extends the prior analysis by including estimates for presenteeism and HRQOL. Whereas we come to similar conclusions with respect to medical expenditures, we find some evidence, at the 10% level of statistical significance (P-value = 0.093), that absenteeism rates improved relative to those who did not lose Z5% weight. We also find some evidence that weight loss moves individuals toward lower levels of presenteeism, although results are only marginally significant for low presenteeism levels (SPS-6 scores between 7 and 9). Together, these results suggest that employee productivity could be improved when a Z5% weight loss is achieved.
The results also reveal that 5% weight loss or greater prevented HRQOL deterioration. This highly statistically significant result (P = 0.03) is consistent with cross-sectional studies showing an inverse relationship between weight and HRQOL. [32] [33] [34] Conservatively, assuming that deterioration in HRQOL is only prevented during the intervention period (1 y), that like in our sample, 17% of the participants lose Z5% weight, and excluding any potential savings in absenteeism or presenteeism, we can compute an upper bound for the cost of an intervention that generates these results. Using a threshold for cost-effectiveness of $50,000 per QALY, an intervention with per capita costs of $221 would be cost-effective (50,000Â 0.026 Â 0.17 = $221). This for instance exceeds the cost of the CDC-WAY web-based program and web-based plus financial incentives (forthcoming).
Although there was no evidence of savings in medical expenditures, this result is not unexpected. Although there is clear evidence from the Diabetes Prevention Program and other studies that weight loss among obese individuals improves diabetes outcomes and risks for numerous chronic conditions, [35] [36] [37] [38] [39] it may be unreasonable to expect substantial improvements in medical expenditures in such a short period among a population of full-time employees, as the adverse health consequences of excess weight are more severe among those in their 50s and beyond. As for the limitations of our study, it is based on a select sample of majority female, overweight/obese employees at colleges and universities in North Carolina who agreed to participate in the research study. Moreover, in response to IRB concerns, 26% of the eligible sample for the claims analysis was removed because of the presence of mental health problems and other conditions ( Table 1) . Excluding these individuals from the analysis may have caused an underestimation of the effect of weight loss on medical expenditures given the high correlation between BMI and poor mental health. 40 Another point is that both our measures for HRQOL and productivity losses are self-reported and might yield biased results if weight loss were to alter the employee's perception of her own health and productivity. It should be noted that self-reported number of days missed at work is a common measure of absenteeism that has been shown to be reliable. 41 Despite these limitations, this study suggests that clinically significant weight loss among overweight employees prevents deterioration in HRQOL and provides some evidence that these improvements may lead to increases in employee productivity. However, over the period analyzed, medical expenditures did not appear to be affected. Future studies should attempt to gather objective data on these outcomes over an extended period, and include additional measures of employee output, such as job turnover, worker's compensation costs, and other measures of productivity, in efforts to provide greater evidence on the long-term economic benefits to employers of sustained weight loss. Research should also continue to identify strategies that are effective in generating and sustaining this level of weight loss among overweight employees so that long-term health and economic benefits are fully realized. 
